Social costs of obesity in the Czech Republic
- PMID: 36449132
- PMCID: PMC9709763
- DOI: 10.1007/s10198-022-01545-8
Social costs of obesity in the Czech Republic
Abstract
Increasing prevalence of obesity (BMI > 30) is a pressing public health issue in the Czech Republic as well as world-wide, affecting up to 2.1 billion people. Increasing trend in the prevalence of obesity in adults and children generates large social costs. The main aim of this study is to estimate both direct and indirect costs of obesity in the Czech Republic. Social costs of obesity are estimated using the cost-of-illness approach. Direct costs (healthcare utilization costs and costs of pharmacotherapy of 20 comorbidities) are estimated using the top-down approach, while indirect costs (absenteeism, presenteeism and premature mortality) are estimated using the human capital approach. In aggregate, the annual costs attributable to obesity in the Czech Republic in 2018 were 40.8 bn CZK (1.6 bn EUR, 0.8% GDP). Direct costs were 14.5 bn CZK (0.6 bn EUR) and accounted for 3.4% of Czech healthcare expenditures. The highest healthcare utilization costs were attributable to type II diabetes (20.6%), ischemic heart disease (18.8%) and osteoarthritis (16.7%). The largest indirect costs were attributable to premature mortality (10 bn CZK/0.39 bn EUR), absenteeism (9.2 bn CZK/0.36 bn EUR) and presenteeism (7.1 bn CZK/0.27 bn EUR). This article demonstrates that obesity is a serious problem with considerable costs. Several preventive interventions should be applied in order to decrease the prevalence of obesity and achieve cost savings.
Keywords: Cost-of-illness study; Czech Republic; Obesity; Social costs.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Partial financial support was received from not-for-profit organization Czech Priorities. The authors have no relevant financial or non-financial interests to disclose.
Figures
References
-
- Dobbs R, Sawers C, Thompson F, Manyika J, Woetzel J, Child P, McKenna S, Spatharou A. Overcoming obesity: An initial economic analysis. USA: McKinsey Global Institute; 2014.
-
- OECD. The Heavy Burden of Obesity. OECD Publishing, 2019a. 10.1787/67450d67-en. https://www.oecd-ilibrary.org/content/publication/67450d67-en
-
- Popkin, B.M., Du, S., Green, W.D., Beck, M.A., Algaith, T., Herbst, C.H., Alsukait, R.F., Alluhidan, M., Alazemi, N., Shekar, M.: Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes. Rev. 21(11), e13128 (2020). 10.1111/obr.13128 - PMC - PubMed
-
- Bruthans, J.: Studie Czech post-MONICA a studie Czech EUROASPIRE: kardiovaskulární rizikové faktory a jejich kontrola v obecné populaci a u osob se stabilní ischemickou chorobou srdeční/Study Czech post-MONICA and study Czech EUROASPIRE: cardiovascular risc factors and their control in general population and in population with ischemic heart disease. http://www.szu.cz/uploads/documents/szu/akce/materialy/14.10.2019/BRUTHA... (2019). Accessed 17 May 2020
-
- NIPH. Výskyt nadváhy a obezity (Prevalence of overweight and obesity). http://www.szu.cz/uploads/documents/chzp/info_listy/Vyskyt_nadvahy_a_obe... (2018). Accessed 17 Oct 2020
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
